Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Pulmonology · Aspirin-Exacerbated Respiratory Disease

Understanding Samter's Triad (AERD)

At a Glance

Samter's Triad, also known as Aspirin-Exacerbated Respiratory Disease (AERD), is a chronic condition characterized by severe adult-onset asthma, recurring nasal polyps, and dangerous respiratory reactions to aspirin or NSAIDs. It is a metabolic disorder that causes intense airway inflammation.

If you have spent years battling severe asthma and “recalcitrant” (stubbornly recurring) nasal polyps, only to find that your symptoms return shortly after every surgery or round of steroids, you may be dealing with Aspirin-Exacerbated Respiratory Disease (AERD) [1][2]. Also known as Samter’s Triad, this condition is often misunderstood and can be deeply frustrating for those living with it [3][4].

Understanding the Triad

AERD is defined by three core components that typically appear in adulthood [5][6]:

  1. Adult-Onset Asthma: Often severe and difficult to control with standard inhalers [7].
  2. Nasal Polyposis: Non-cancerous growths in the nasal passages that cause chronic congestion and a significant loss of smell (anosmia) [3][4].
  3. Aspirin/NSAID Sensitivity: Respiratory reactions—such as wheezing, coughing, or sinus pressure—that occur after taking aspirin or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen (Advil, Motrin) or naproxen (Aleve) [8][9].

While it may feel like a rare struggle, AERD affects approximately 7% of all adults with asthma [10].

A Metabolic Issue, Not a Standard Allergy

It is common for patients to assume their symptoms are caused by an allergy to pollen, pets, or dust. However, AERD is fundamentally different from a traditional IgE-mediated allergy [11].

In a standard allergy, your immune system overreacts to an external trigger. In contrast, AERD is a metabolic disorder involving an imbalance in how your body processes arachidonic acid (a type of fatty acid) [12][13].

  • Leukotriene Overproduction: Your body produces massive amounts of cysteinyl leukotrienes, which are powerful chemicals that cause intense inflammation, swelling, and mucus production in the airways [14][15].
  • Prostaglandin Imbalance: You have a deficiency of Prostaglandin E2 (PGE2), which normally helps protect the lungs and keep inflammation in check [15][16].

When you take aspirin or an NSAID, it blocks a specific enzyme (COX-1) that is already struggling, leading to a “shutdown” of protective pathways and a massive surge in inflammatory chemicals [15][13].

Important: Accidental ingestion of NSAIDs does not just fuel chronic inflammation; it is an immediate medical emergency for someone with AERD, as it triggers a sudden, severe, and potentially life-threatening asthma attack (bronchospasm) [8][9].

The Impact of Delayed Diagnosis

Many people with AERD suffer for years before receiving an accurate diagnosis. This delay is often because patients may not realize their “sinus flares” are actually reactions to medications, or they may have naturally stopped taking NSAIDs because they “just didn’t feel right” after using them [17][18].

Warning: Hidden NSAIDs and Salicylates
Aspirin and NSAIDs are frequently hidden in over-the-counter cold, flu, and stomach medications, such as Alka-Seltzer and Pepto-Bismol [17]. Always check labels carefully, as accidental ingestion can trigger an acute respiratory crisis.

The physical and emotional toll of AERD can be heavy:

  • Loss of Smell (Anosmia): This is often one of the most distressing symptoms, affecting the ability to enjoy food and detect environmental hazards [4][19].
  • Surgical Frustration: Polyps in AERD patients tend to grow back much faster after surgery than in people with other types of sinus disease [1][20].
  • Alcohol Sensitivity: Many patients (up to 75%) also experience respiratory symptoms or facial flushing after drinking even small amounts of alcohol [21][6].

Recognizing that your symptoms are part of a single, unified metabolic condition is the first step toward more effective, targeted treatment [2][22].

Common questions in this guide

What is Samter's Triad?
Samter's Triad, or AERD, is a chronic medical condition defined by three main features: adult-onset asthma, recurring nasal polyps, and respiratory reactions (like wheezing or sinus pressure) after taking aspirin or NSAIDs.
Why do I react to aspirin and NSAIDs if it isn't an allergy?
AERD is a metabolic disorder, not a traditional allergy. It involves an imbalance in how your body processes fatty acids, leading to an overproduction of inflammatory chemicals called leukotrienes. Taking NSAIDs blocks a protective enzyme, which triggers a massive surge in these inflammatory chemicals.
Why do my nasal polyps keep coming back after surgery?
Polyps in patients with AERD tend to regrow much faster than in people with other types of sinus disease. This rapid regrowth is driven by the continuous, severe underlying inflammation and leukotriene overproduction characteristic of the condition.
Can alcohol trigger AERD symptoms?
Yes, many patients with AERD experience respiratory symptoms or facial flushing after drinking alcohol. Up to 75% of people with the condition react to even small amounts of alcohol, particularly red wine or beer.
What happens if someone with AERD accidentally takes ibuprofen or aspirin?
Accidentally taking an NSAID can trigger a sudden, severe, and potentially life-threatening asthma attack (bronchospasm). NSAIDs are often hidden in over-the-counter cold, flu, and stomach medications, so it is critical to read labels carefully.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you suspect I have Samter's Triad, and how does that change my treatment plan compared to standard asthma or sinus care?
  2. 2.What is my specific risk of nasal polyp recurrence after surgery, and how does an AERD diagnosis affect that risk?
  3. 3.Given my history, should I undergo a medically supervised aspirin challenge to confirm the diagnosis?
  4. 4.Are my current asthma and sinus medications addressing the leukotriene overproduction associated with AERD?
  5. 5.What is our emergency action plan if I accidentally ingest an NSAID?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?

    O'Brien EK, Jerschow E, Divekar RD

    Otolaryngologic clinics of North America 2024; (57(2)):265-278 doi:10.1016/j.otc.2023.09.006.

    PMID: 37833102
  2. 2

    Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.

    Stevenson DD, White AA

    Immunology and allergy clinics of North America 2016; (36(4)):643-655 doi:10.1016/j.iac.2016.06.002.

    PMID: 27712760
  3. 3

    Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

    Roland LT, Nagy C, Wang H, et al.

    International forum of allergy & rhinology 2020; (10(2)):190-193 doi:10.1002/alr.22471.

    PMID: 31693796
  4. 4

    Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.

    Spielman DB, Overdevest J, Gudis DA

    World journal of otorhinolaryngology - head and neck surgery 2020; (6(4)):207-213 doi:10.1016/j.wjorl.2020.07.001.

    PMID: 33336175
  5. 5

    Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.

    Luskin K, Thakrar H, White A

    Immunology and allergy clinics of North America 2020; (40(2)):329-343 doi:10.1016/j.iac.2019.12.002.

    PMID: 32278455
  6. 6

    Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future.

    Kennedy JL, Stoner AN, Borish L

    American journal of rhinology & allergy 2016; (30(6)):407-413 doi:10.2500/ajra.2016.30.4370.

    PMID: 28124651
  7. 7

    Surgical outcomes in aspirin-exacerbated respiratory disease without aspirin desensitization.

    Grose E, Lee DJ, Yip J, et al.

    International forum of allergy & rhinology 2020; (10(10)):1149-1157 doi:10.1002/alr.22626.

    PMID: 32558318
  8. 8

    Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

    Roland LT, Wang H, Mehta CC, et al.

    International forum of allergy & rhinology 2019; (9(12)):1420-1423 doi:10.1002/alr.22412.

    PMID: 31442000
  9. 9

    A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.

    Sommer DD, Rotenberg BW, Sowerby LJ, et al.

    International forum of allergy & rhinology 2016; (6(4)):385-91 doi:10.1002/alr.21678.

    PMID: 26751262
  10. 10

    Aspirin-Exacerbated Respiratory Disease.

    White AA, Stevenson DD

    The New England journal of medicine 2018; (379(11)):1060-1070 doi:10.1056/NEJMra1712125.

    PMID: 30207919
  11. 11

    Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity.

    Corey KB, Cahill KN

    Immunology and allergy clinics of North America 2022; (42(2)):421-432 doi:10.1016/j.iac.2021.12.005.

    PMID: 35469627
  12. 12

    Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.

    Parker AR, Ayars AG, Altman MC, Henderson WR

    Immunology and allergy clinics of North America 2016; (36(4)):749-763 doi:10.1016/j.iac.2016.06.009.

    PMID: 27712768
  13. 13

    Cysteinyl Leukotrienes in Allergic Inflammation.

    Lee M, Boyce JA, Barrett NA

    Annual review of pathology 2025; (20(1)):115-141 doi:10.1146/annurev-pathmechdis-111523-023509.

    PMID: 39374430
  14. 14

    Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.

    Trinh HKT, Pham DL, Choi Y, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2018; (48(11)):1464-1473 doi:10.1111/cea.13253.

    PMID: 30126026
  15. 15

    Low Prostaglandin E2 but High Prostaglandin D2, a Paradoxical Dissociation in Arachidonic Acid Metabolism in Aspirin-Exacerbated Airway Disease: Role of Airway Epithelium.

    Picado C, Machado-Carvalho L, Roca-Ferrer J

    Journal of clinical medicine 2024; (13(23)) doi:10.3390/jcm13237416.

    PMID: 39685875
  16. 16

    COX-1 mediates IL-33-induced extracellular signal-regulated kinase activation in mast cells: Implications for aspirin sensitivity.

    Pan D, Buchheit KM, Samuchiwal SK, et al.

    The Journal of allergy and clinical immunology 2019; (143(3)):1047-1057.e8 doi:10.1016/j.jaci.2018.06.033.

    PMID: 30017554
  17. 17

    Diagnostic Role of Aspirin Challenge in NSAID-Exacerbated Respiratory Disease: A Prospective Single-Center Study in China.

    Xiao H, Xu F, Zhang L, et al.

    Allergy, asthma & immunology research 2026; (18(3)):379-390 doi:10.4168/aair.2026.18.3.379.

    PMID: 42223037
  18. 18

    Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment.

    Ley-Tomas JJ, Xicotencatl-Tellez AM, García-Cruz ML, Jiménez-Chobillon MA

    Frontiers in allergy 2024; (5()):1462985 doi:10.3389/falgy.2024.1462985.

    PMID: 39665076
  19. 19

    Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life.

    Tchekmedyian R, Lundberg M, Buchheit KM, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2022; (52(12)):1414-1421 doi:10.1111/cea.14157.

    PMID: 35506180
  20. 20

    Aspirin-Exacerbated Respiratory Disease.

    Walgama ES, Hwang PH

    Otolaryngologic clinics of North America 2017; (50(1)):83-94 doi:10.1016/j.otc.2016.08.007.

    PMID: 27888917
  21. 21

    Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease.

    Glicksman JT, Parasher AK, Doghramji L, et al.

    International forum of allergy & rhinology 2018; (8(10)):1093-1097 doi:10.1002/alr.22168.

    PMID: 30007020
  22. 22

    The Utility of Nasal Challenges to Phenotype Asthma Patients.

    Bentabol-Ramos G, Saenz de Santa Maria-Garcia R, Vidal-Diaz M, et al.

    International journal of molecular sciences 2022; (23(9)) doi:10.3390/ijms23094838.

    PMID: 35563226

This page provides educational information about Samter's Triad (AERD) and is not a substitute for professional medical advice. Always consult your pulmonologist or allergist before changing your asthma medications or attempting an aspirin challenge.

Get notified when new evidence is published on asthma, nasal polyps, and aspirin intolerance.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.